4//SEC Filing
McCarthy Sean A. 4
Accession 0001610717-25-000372
CIK 0001501989other
Filed
Nov 9, 7:00 PM ET
Accepted
Nov 10, 4:05 PM ET
Size
6.1 KB
Accession
0001610717-25-000372
Insider Transaction Report
Form 4
McCarthy Sean A.
DirectorCEO
Transactions
- Sale
Class A Common Stock
2025-11-06$4.54/sh−101,793$461,906→ 987,891 total
Holdings
- 93,158(indirect: See footnote)
Class A Common Stock
Footnotes (4)
- [F1]The transactions reported herein were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan, adopted on August 27, 2024.
- [F2]This transaction was executed in multiple trades at prices ranging from $4.50 to $4.62, inclusive. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
- [F3]Includes 488,750 restricted stock units.
- [F4]Shares held by Sean A. McCarthy 2018 Trust, of which the Reporting Person is trustee.
Documents
Issuer
CytomX Therapeutics, Inc.
CIK 0001501989
Entity typeother
Related Parties
1- filerCIK 0001654058
Filing Metadata
- Form type
- 4
- Filed
- Nov 9, 7:00 PM ET
- Accepted
- Nov 10, 4:05 PM ET
- Size
- 6.1 KB